
\section*{Artery Coronary}
\begin{figure}[h!]
\centering
\includegraphics[width=.9\textwidth]{figures/tissue_prediction_from_Artery_Coronary.pdf}
\end{figure}



\subsection*{Community with ID 1}
This community has the following genes: C1QA, C1QC, C1QB, FOLR2
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 1}\\
\toprule
Adjusted \newline P-value &                                                                         Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
                 0.000057 &  Classical antibody-mediated complement activation Homo sapiens R-HSA-173623 \\
                 0.000042 &                   Creation of C4 and C2 activators Homo sapiens R-HSA-166786 \\
                 0.000047 &                   Initial triggering of complement Homo sapiens R-HSA-166663 \\
                 0.000094 &                                 Complement cascade Homo sapiens R-HSA-166658 \\
\end{longtable}


\begin{longtable}{lrrr}
\caption{Connectivity of community 1}\\
\toprule
{} & \rot{C1QC} & \rot{C1QB} & \rot{FOLR2} \\
\midrule
\endhead
\midrule
\multicolumn{4}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
C1QA &       1.21 &       1.29 &        0.89 \\
C1QC &            &       1.57 &        0.61 \\
C1QB &            &            &        0.64 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_1.pdf}
\caption{Community 1 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 3}
This community has the following genes: PADI4, CSF3R, S100A9, S100A12, S100A8, FCGR3B, CXCR2, CXCR1, PROK2, ARG1, MGAM, NFE2, MMP25, C19orf59
\\
This community has no enriched pathways below adjusted p-value $< 0.05$.

\begin{longtable}{lrrrrrrrrrrrrr}
\caption{Connectivity of community 3}\\
\toprule
{} & \rot{CSF3R} & \rot{S100A9} & \rot{S100A12} & \rot{S100A8} & \rot{FCGR3B} & \rot{CXCR2} & \rot{CXCR1} & \rot{PROK2} & \rot{ARG1} & \rot{MGAM} & \rot{NFE2} & \rot{MMP25} & \rot{C19orf59} \\
\midrule
\endhead
\midrule
\multicolumn{14}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
PADI4   &         0.7 &         0.54 &          0.82 &         0.70 &         0.76 &        0.74 &        0.90 &        0.73 &       0.86 &       0.83 &       0.77 &        0.70 &           0.59 \\
CSF3R   &             &         0.57 &          0.66 &         0.67 &         0.89 &        0.82 &        0.89 &        0.77 &       0.59 &       0.72 &       0.89 &        0.82 &           0.81 \\
S100A9  &             &              &          0.78 &         1.40 &         0.49 &        0.49 &        0.56 &        0.61 &       0.52 &       0.62 &       0.69 &        0.58 &           0.70 \\
S100A12 &             &              &               &         1.04 &         0.60 &        0.69 &        0.76 &        0.79 &       0.71 &       0.70 &       0.84 &        0.71 &           0.90 \\
S100A8  &             &              &               &              &         0.59 &        0.61 &        0.67 &        0.72 &       0.60 &       0.67 &       0.81 &        0.65 &           0.85 \\
FCGR3B  &             &              &               &              &              &        1.16 &        1.10 &        0.80 &       0.66 &       0.77 &       0.67 &        0.73 &           0.58 \\
CXCR2   &             &              &               &              &              &             &        1.22 &        0.73 &       0.61 &       0.84 &       0.70 &        0.81 &           0.70 \\
CXCR1   &             &              &               &              &              &             &             &        0.85 &       0.67 &       0.88 &       0.84 &        0.90 &           0.73 \\
PROK2   &             &              &               &              &              &             &             &             &       0.61 &       0.69 &       0.86 &        0.75 &           0.70 \\
ARG1    &             &              &               &              &              &             &             &             &            &       0.64 &       0.59 &        0.63 &           0.43 \\
MGAM    &             &              &               &              &              &             &             &             &            &            &       0.70 &        0.77 &           0.74 \\
NFE2    &             &              &               &              &              &             &             &             &            &            &            &        0.81 &           0.80 \\
MMP25   &             &              &               &              &              &             &             &             &            &            &            &             &           0.66 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_3.pdf}
\caption{Community 3 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 4}
This community has the following genes: LCK, CD2, CD247, CD8A, CD8B, ZAP70, IL7R, ITK, ANO9, CD6, CD3E, CD3D, CD3G, BCL11B, RLTPR, IKZF3
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 4}\\
\toprule
Adjusted \newline P-value &                                                                                                                      Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
             4.585613e-13 &                                                        Generation of second messenger molecules Homo sapiens R-HSA-202433 \\
             3.716691e-12 &                                                Translocation of ZAP-70 to Immunological synapse Homo sapiens R-HSA-202430 \\
             1.160075e-09 &                                                                                   TCR signaling Homo sapiens R-HSA-202403 \\
             2.640405e-09 &                                                      Phosphorylation of CD3 and TCR zeta chains Homo sapiens R-HSA-202427 \\
             3.266109e-09 &                                                                                  PD-1 signaling Homo sapiens R-HSA-389948 \\
             3.703779e-07 &                                                                         Adaptive Immune System Homo sapiens R-HSA-1280218 \\
             3.486553e-07 &                        Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell Homo sapiens R-HSA-198933 \\
             4.251671e-07 &                                                                Costimulation by the CD28 family Homo sapiens R-HSA-388841 \\
             1.908144e-06 &                                                                        Downstream TCR signaling Homo sapiens R-HSA-202424 \\
             5.923055e-06 &                                                                                   Immune System Homo sapiens R-HSA-168256 \\
             1.890704e-04 &                                   The role of Nef in HIV-1 replication and disease pathogenesis Homo sapiens R-HSA-164952 \\
             2.135992e-03 &                                                                     Nef and signal transduction Homo sapiens R-HSA-164944 \\
             1.469847e-02 &  Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters Homo sapiens R-HSA-164938 \\
             1.508739e-02 &                                                                Host Interactions of HIV factors Homo sapiens R-HSA-162909 \\
\end{longtable}


\begin{longtable}{lrrrrrrrrrrrrrrr}
\caption{Connectivity of community 4}\\
\toprule
{} & \rot{CD2} & \rot{CD247} & \rot{CD8A} & \rot{CD8B} & \rot{ZAP70} & \rot{IL7R} & \rot{ITK} & \rot{ANO9} & \rot{CD6} & \rot{CD3E} & \rot{CD3D} & \rot{CD3G} & \rot{BCL11B} & \rot{RLTPR} & \rot{IKZF3} \\
\midrule
\endhead
\midrule
\multicolumn{16}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
LCK    &      0.71 &        0.69 &       0.52 &       0.42 &        0.93 &       0.68 &      0.68 &       0.79 &      0.83 &       0.91 &       0.72 &       0.54 &         0.74 &        0.79 &        0.82 \\
CD2    &           &        0.58 &       0.56 &       0.54 &        0.81 &       0.69 &      0.59 &       0.59 &      0.85 &       0.93 &       0.82 &       0.72 &         0.64 &        0.61 &        0.69 \\
CD247  &           &             &       0.46 &       0.37 &        0.81 &       0.46 &      0.67 &       0.48 &      0.61 &       0.60 &       0.49 &       0.45 &         0.56 &        0.56 &        0.60 \\
CD8A   &           &             &            &       1.00 &        0.61 &       0.45 &      0.62 &       0.49 &      0.50 &       0.86 &       0.71 &       0.58 &         0.47 &        0.45 &        0.54 \\
CD8B   &           &             &            &            &        0.49 &       0.36 &      0.50 &       0.43 &      0.36 &       0.73 &       0.59 &       0.58 &         0.35 &        0.42 &        0.41 \\
ZAP70  &           &             &            &            &             &       0.69 &      0.84 &       0.74 &      0.84 &       0.92 &       0.79 &       0.68 &         0.78 &        0.86 &        0.86 \\
IL7R   &           &             &            &            &             &            &      0.91 &       0.66 &      0.76 &       0.85 &       0.60 &       0.44 &         0.63 &        0.60 &        0.67 \\
ITK    &           &             &            &            &             &            &           &       0.69 &      0.69 &       0.91 &       0.53 &       0.50 &         0.77 &        0.68 &        0.74 \\
ANO9   &           &             &            &            &             &            &           &            &      0.60 &       0.69 &       0.64 &       0.49 &         0.56 &        0.86 &        0.70 \\
CD6    &           &             &            &            &             &            &           &            &           &       0.80 &       0.71 &       0.51 &         0.74 &        0.62 &        0.71 \\
CD3E   &           &             &            &            &             &            &           &            &           &            &       0.89 &       0.80 &         0.82 &        0.83 &        0.74 \\
CD3D   &           &             &            &            &             &            &           &            &           &            &            &       0.76 &         0.59 &        0.56 &        0.63 \\
CD3G   &           &             &            &            &             &            &           &            &           &            &            &            &         0.56 &        0.59 &        0.53 \\
BCL11B &           &             &            &            &             &            &           &            &           &            &            &            &              &        0.63 &        0.77 \\
RLTPR  &           &             &            &            &             &            &           &            &           &            &            &            &              &             &        0.81 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_4.pdf}
\caption{Community 4 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 6}
This community has the following genes: CPA3, KIT, RAB44, SLC18A2, MS4A2, HDC, TPSAB1
\\
This community has no enriched pathways below adjusted p-value $< 0.05$.

\begin{longtable}{lrrrrrr}
\caption{Connectivity of community 6}\\
\toprule
{} & \rot{KIT} & \rot{RAB44} & \rot{SLC18A2} & \rot{MS4A2} & \rot{HDC} & \rot{TPSAB1} \\
\midrule
\endhead
\midrule
\multicolumn{7}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
CPA3    &       1.0 &        0.77 &          0.87 &        1.02 &      0.91 &         1.36 \\
KIT     &           &        0.83 &          0.82 &        0.79 &      0.89 &         0.97 \\
RAB44   &           &             &          0.68 &        0.66 &      0.72 &         0.76 \\
SLC18A2 &           &             &               &        0.81 &      0.77 &         0.74 \\
MS4A2   &           &             &               &             &      0.85 &         0.88 \\
HDC     &           &             &               &             &           &         0.78 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_6.pdf}
\caption{Community 6 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 7}
This community has the following genes: ZMAT3, SPATA18, PTCHD4, DDB2
\\
This community has no enriched pathways below adjusted p-value $< 0.05$.

\begin{longtable}{lrrr}
\caption{Connectivity of community 7}\\
\toprule
{} & \rot{SPATA18} & \rot{PTCHD4} & \rot{DDB2} \\
\midrule
\endhead
\midrule
\multicolumn{4}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
ZMAT3   &          0.85 &         0.84 &       0.83 \\
SPATA18 &               &         0.58 &       0.77 \\
PTCHD4  &               &              &       0.65 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_7.pdf}
\caption{Community 7 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 10}
This community has the following genes: FCRL5, IGJ, RP11.1280I22.1, POU2AF1
\\
This community has no enriched pathways below adjusted p-value $< 0.05$.

\begin{longtable}{lrrr}
\caption{Connectivity of community 10}\\
\toprule
{} & \rot{IGJ} & \rot{RP11.1280I22.1} & \rot{POU2AF1} \\
\midrule
\endhead
\midrule
\multicolumn{4}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
FCRL5          &      0.85 &                 0.97 &          0.90 \\
IGJ            &           &                 0.94 &          0.75 \\
RP11.1280I22.1 &           &                      &          0.83 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_10.pdf}
\caption{Community 10 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 11}
This community has the following genes: CD74, HLA.DRA, HLA.DRB1, HLA.DQA1, HLA.DQB1, HLA.DOA, HLA.DPA1, HLA.DPB1
\\
This community has no enriched pathways below adjusted p-value $< 0.05$.

\begin{longtable}{lrrrrrrr}
\caption{Connectivity of community 11}\\
\toprule
{} & \rot{HLA.DRA} & \rot{HLA.DRB1} & \rot{HLA.DQA1} & \rot{HLA.DQB1} & \rot{HLA.DOA} & \rot{HLA.DPA1} & \rot{HLA.DPB1} \\
\midrule
\endhead
\midrule
\multicolumn{8}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
CD74     &           1.4 &           1.12 &           0.83 &           0.50 &          0.89 &           1.30 &           1.17 \\
HLA.DRA  &               &           1.05 &           0.77 &           0.43 &          0.90 &           1.22 &           1.21 \\
HLA.DRB1 &               &                &           0.96 &           0.71 &          0.79 &           1.06 &           0.86 \\
HLA.DQA1 &               &                &                &           1.04 &          0.70 &           0.78 &           0.64 \\
HLA.DQB1 &               &                &                &                &          0.36 &           0.49 &           0.35 \\
HLA.DOA  &               &                &                &                &               &           0.78 &           0.79 \\
HLA.DPA1 &               &                &                &                &               &                &           1.15 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_11.pdf}
\caption{Community 11 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 17}
This community has the following genes: CTRC, CELA2A, CELA2B, CELA3B, CELA3A, AMY2A, REG1B, REG1A, REG3A, CPB1, CLPS, CPA2, CPA1, PRSS1, PRSS3, CEL, PNLIP, PNLIPRP1, INS, PLA2G1B, GP2, CTRB2, CTRB1, SYCN, RBPJL, REG3G
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 17}\\
\toprule
Adjusted \newline P-value &                                                                             Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
             7.574865e-08 &  Cobalamin (Cbl, vitamin B12) transport and metabolism Homo sapiens R-HSA-196741 \\
             4.711312e-07 &                   Metabolism of vitamins and cofactors Homo sapiens R-HSA-196854 \\
             2.691304e-06 &                             Digestion of dietary lipid Homo sapiens R-HSA-192456 \\
             5.908370e-05 &     Metabolism of water-soluble vitamins and cofactors Homo sapiens R-HSA-196849 \\
             4.533917e-04 &                                            Metabolism Homo sapiens R-HSA-1430728 \\
             5.238943e-04 &            Lipid digestion, mobilization, and transport Homo sapiens R-HSA-73923 \\
             2.061961e-03 &               Activation of Matrix Metalloproteinases Homo sapiens R-HSA-1592389 \\
\end{longtable}


\begin{longtable}{lrrrrrrrrrrrrrrrrrrrrrrrrr}
\caption{Connectivity of community 17}\\
\toprule
{} & \rot{CELA2A} & \rot{CELA2B} & \rot{CELA3B} & \rot{CELA3A} & \rot{AMY2A} & \rot{REG1B} & \rot{REG1A} & \rot{REG3A} & \rot{CPB1} & \rot{CLPS} & \rot{CPA2} & \rot{CPA1} & \rot{PRSS1} & \rot{PRSS3} & \rot{CEL} & \rot{PNLIP} & \rot{PNLIPRP1} & \rot{INS} & \rot{PLA2G1B} & \rot{GP2} & \rot{CTRB2} & \rot{CTRB1} & \rot{SYCN} & \rot{RBPJL} & \rot{REG3G} \\
\midrule
\endhead
\midrule
\multicolumn{26}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
CTRC     &          1.1 &         0.86 &         1.31 &         1.23 &        0.97 &        0.91 &        1.06 &        0.62 &       1.05 &       1.27 &       1.19 &       1.13 &        1.32 &        0.82 &      1.17 &        1.19 &           1.17 &      0.66 &          1.32 &      1.22 &        1.19 &        1.23 &       1.27 &        0.79 &        0.67 \\
CELA2A   &              &         0.96 &         1.26 &         1.20 &        0.99 &        0.79 &        0.95 &        0.47 &       1.19 &       1.20 &       1.04 &       1.17 &        1.34 &        0.86 &      1.12 &        1.31 &           1.06 &      0.62 &          1.17 &      1.17 &        1.15 &        1.14 &       1.14 &        0.75 &        0.54 \\
CELA2B   &              &              &         0.97 &         0.90 &        0.80 &        0.64 &        0.79 &        0.45 &       0.92 &       0.88 &       0.85 &       0.86 &        0.99 &        0.72 &      0.87 &        0.98 &           0.82 &      0.56 &          0.90 &      0.90 &        0.88 &        0.90 &       0.94 &        0.64 &        0.42 \\
CELA3B   &              &              &              &         1.70 &        1.10 &        1.04 &        1.27 &        0.63 &       1.38 &       1.68 &       1.39 &       1.40 &        1.71 &        0.94 &      1.32 &        1.54 &           1.46 &      0.74 &          1.54 &      1.66 &        1.54 &        1.48 &       1.39 &        0.89 &        0.66 \\
CELA3A   &              &              &              &              &        0.99 &        1.10 &        1.34 &        0.67 &       1.35 &       1.67 &       1.31 &       1.30 &        1.68 &        0.89 &      1.32 &        1.59 &           1.43 &      0.82 &          1.51 &      1.72 &        1.56 &        1.50 &       1.34 &        0.83 &        0.69 \\
AMY2A    &              &              &              &              &             &        0.66 &        0.80 &        0.45 &       0.93 &       1.04 &       0.98 &       0.97 &        1.11 &        0.78 &      0.98 &        1.13 &           0.98 &      0.50 &          1.01 &      0.97 &        1.02 &        0.99 &       1.06 &        0.70 &        0.53 \\
REG1B    &              &              &              &              &             &             &        1.61 &        0.97 &       0.94 &       1.05 &       0.93 &       0.92 &        1.00 &        0.69 &      0.95 &        0.88 &           1.13 &      0.74 &          1.06 &      1.24 &        1.11 &        1.05 &       0.83 &        0.79 &        0.90 \\
REG1A    &              &              &              &              &             &             &             &        0.92 &       1.15 &       1.34 &       1.12 &       1.18 &        1.25 &        0.85 &      1.13 &        1.11 &           1.32 &      0.77 &          1.25 &      1.52 &        1.29 &        1.23 &       1.06 &        0.87 &        0.85 \\
REG3A    &              &              &              &              &             &             &             &             &       0.60 &       0.64 &       0.59 &       0.57 &        0.61 &        0.57 &      0.64 &        0.55 &           0.67 &      0.59 &          0.64 &      0.71 &        0.66 &        0.62 &       0.59 &        0.59 &        0.81 \\
CPB1     &              &              &              &              &             &             &             &             &            &       1.27 &       1.26 &       1.37 &        1.34 &        0.89 &      1.25 &        1.31 &           1.28 &      0.76 &          1.20 &      1.33 &        1.31 &        1.26 &       1.22 &        0.80 &        0.68 \\
CLPS     &              &              &              &              &             &             &             &             &            &            &       1.32 &       1.34 &        1.65 &        0.88 &      1.20 &        1.48 &           1.36 &      0.74 &          1.53 &      1.57 &        1.49 &        1.44 &       1.37 &        0.81 &        0.66 \\
CPA2     &              &              &              &              &             &             &             &             &            &            &            &       1.38 &        1.39 &        0.87 &      1.17 &        1.26 &           1.26 &      0.72 &          1.27 &      1.32 &        1.32 &        1.30 &       1.24 &        0.82 &        0.69 \\
CPA1     &              &              &              &              &             &             &             &             &            &            &            &            &        1.40 &        0.90 &      1.23 &        1.33 &           1.24 &      0.70 &          1.25 &      1.34 &        1.28 &        1.20 &       1.27 &        0.86 &        0.71 \\
PRSS1    &              &              &              &              &             &             &             &             &            &            &            &            &             &        0.88 &      1.32 &        1.83 &           1.36 &      0.74 &          1.43 &      1.60 &        1.54 &        1.57 &       1.42 &        0.84 &        0.65 \\
PRSS3    &              &              &              &              &             &             &             &             &            &            &            &            &             &             &      0.83 &        0.91 &           0.87 &      0.57 &          0.89 &      0.86 &        0.86 &        0.84 &       0.88 &        0.75 &        0.57 \\
CEL      &              &              &              &              &             &             &             &             &            &            &            &            &             &             &           &        1.23 &           1.26 &      0.70 &          1.21 &      1.27 &        1.30 &        1.26 &       1.17 &        0.77 &        0.68 \\
PNLIP    &              &              &              &              &             &             &             &             &            &            &            &            &             &             &           &             &           1.32 &      0.75 &          1.31 &      1.50 &        1.35 &        1.41 &       1.49 &        0.81 &        0.56 \\
PNLIPRP1 &              &              &              &              &             &             &             &             &            &            &            &            &             &             &           &             &                &      0.73 &          1.34 &      1.49 &        1.44 &        1.36 &       1.27 &        0.87 &        0.79 \\
INS      &              &              &              &              &             &             &             &             &            &            &            &            &             &             &           &             &                &           &          0.78 &      0.80 &        0.76 &        0.77 &       0.74 &        0.54 &        0.49 \\
PLA2G1B  &              &              &              &              &             &             &             &             &            &            &            &            &             &             &           &             &                &           &               &      1.38 &        1.41 &        1.40 &       1.37 &        0.87 &        0.65 \\
GP2      &              &              &              &              &             &             &             &             &            &            &            &            &             &             &           &             &                &           &               &           &        1.48 &        1.50 &       1.27 &        0.92 &        0.74 \\
CTRB2    &              &              &              &              &             &             &             &             &            &            &            &            &             &             &           &             &                &           &               &           &             &        1.47 &       1.26 &        0.82 &        0.74 \\
CTRB1    &              &              &              &              &             &             &             &             &            &            &            &            &             &             &           &             &                &           &               &           &             &             &       1.28 &        0.88 &        0.66 \\
SYCN     &              &              &              &              &             &             &             &             &            &            &            &            &             &             &           &             &                &           &               &           &             &             &            &        0.85 &        0.62 \\
RBPJL    &              &              &              &              &             &             &             &             &            &            &            &            &             &             &           &             &                &           &               &           &             &             &            &             &        0.59 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_17.pdf}
\caption{Community 17 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 20}
This community has the following genes: FLG2, C1orf68, KPRP, IVL, LOR, LY6D, CALML5, TRIM29, KRT5, KRT2, KRT1, KRT77, DCD, SCEL, SERPINA12, KRT15, DSC1, DSG1, SERPINB5, CASP14, KRTDAP, SBSN, LGALS7B
\\
This community has no enriched pathways below adjusted p-value $< 0.05$.

\begin{longtable}{lrrrrrrrrrrrrrrrrrrrrrr}
\caption{Connectivity of community 20}\\
\toprule
{} & \rot{C1orf68} & \rot{KPRP} & \rot{IVL} & \rot{LOR} & \rot{LY6D} & \rot{CALML5} & \rot{TRIM29} & \rot{KRT5} & \rot{KRT2} & \rot{KRT1} & \rot{KRT77} & \rot{DCD} & \rot{SCEL} & \rot{SERPINA12} & \rot{KRT15} & \rot{DSC1} & \rot{DSG1} & \rot{SERPINB5} & \rot{CASP14} & \rot{KRTDAP} & \rot{SBSN} & \rot{LGALS7B} \\
\midrule
\endhead
\midrule
\multicolumn{23}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
FLG2      &          0.89 &       0.93 &      0.36 &      1.13 &       0.36 &         1.10 &         0.51 &       0.49 &       1.11 &       1.20 &        0.88 &      0.85 &       0.38 &            0.84 &        0.43 &       0.71 &       1.03 &           0.69 &         1.09 &         1.05 &       0.95 &          0.80 \\
C1orf68   &               &       0.83 &      0.27 &      0.92 &       0.31 &         0.86 &         0.49 &       0.39 &       0.85 &       0.90 &        0.65 &      0.67 &       0.28 &            0.67 &        0.40 &       0.62 &       0.76 &           0.58 &         0.82 &         0.85 &       0.77 &          0.71 \\
KPRP      &               &            &      0.37 &      0.97 &       0.41 &         0.92 &         0.55 &       0.52 &       0.85 &       0.89 &        0.74 &      0.66 &       0.35 &            0.78 &        0.52 &       0.59 &       0.73 &           0.66 &         0.82 &         0.84 &       0.88 &          0.68 \\
IVL       &               &            &           &      0.39 &       0.75 &         0.45 &         0.65 &       0.81 &       0.34 &       0.46 &        0.46 &      0.29 &       0.68 &            0.33 &        0.70 &       0.25 &       0.43 &           0.70 &         0.33 &         0.38 &       0.63 &          0.47 \\
LOR       &               &            &           &           &       0.36 &         1.22 &         0.60 &       0.47 &       1.15 &       1.21 &        0.90 &      0.76 &       0.32 &            0.86 &        0.41 &       0.69 &       0.93 &           0.68 &         0.98 &         1.06 &       0.97 &          0.76 \\
LY6D      &               &            &           &           &            &         0.40 &         0.67 &       0.83 &       0.31 &       0.41 &        0.35 &      0.29 &       0.58 &            0.33 &        0.74 &       0.25 &       0.41 &           0.60 &         0.32 &         0.36 &       0.63 &          0.53 \\
CALML5    &               &            &           &           &            &              &         0.62 &       0.56 &       1.17 &       1.32 &        0.91 &      0.79 &       0.39 &            0.85 &        0.50 &       0.74 &       0.98 &           0.77 &         1.01 &         1.10 &       1.00 &          0.78 \\
TRIM29    &               &            &           &           &            &              &              &       1.04 &       0.59 &       0.67 &        0.55 &      0.49 &       0.67 &            0.57 &        1.00 &       0.46 &       0.65 &           0.72 &         0.58 &         0.61 &       0.87 &          0.63 \\
KRT5      &               &            &           &           &            &              &              &            &       0.52 &       0.61 &        0.52 &      0.43 &       0.88 &            0.49 &        1.29 &       0.40 &       0.63 &           0.80 &         0.49 &         0.51 &       0.88 &          0.58 \\
KRT2      &               &            &           &           &            &              &              &            &            &       1.33 &        0.84 &      0.87 &       0.37 &            0.88 &        0.44 &       0.84 &       0.99 &           0.72 &         1.07 &         1.05 &       0.92 &          0.80 \\
KRT1      &               &            &           &           &            &              &              &            &            &            &        0.96 &      0.88 &       0.42 &            0.91 &        0.51 &       0.82 &       1.12 &           0.82 &         1.14 &         1.11 &       1.10 &          0.88 \\
KRT77     &               &            &           &           &            &              &              &            &            &            &             &      0.67 &       0.41 &            0.80 &        0.45 &       0.64 &       0.87 &           0.65 &         0.83 &         0.82 &       0.78 &          0.64 \\
DCD       &               &            &           &           &            &              &              &            &            &            &             &           &       0.35 &            0.64 &        0.41 &       0.64 &       0.69 &           0.57 &         0.78 &         0.72 &       0.76 &          0.64 \\
SCEL      &               &            &           &           &            &              &              &            &            &            &             &           &            &            0.38 &        0.85 &       0.35 &       0.49 &           0.62 &         0.36 &         0.39 &       0.55 &          0.40 \\
SERPINA12 &               &            &           &           &            &              &              &            &            &            &             &           &            &                 &        0.46 &       0.68 &       0.81 &           0.62 &         0.83 &         0.76 &       0.80 &          0.66 \\
KRT15     &               &            &           &           &            &              &              &            &            &            &             &           &            &                 &             &       0.28 &       0.51 &           0.74 &         0.41 &         0.42 &       0.74 &          0.51 \\
DSC1      &               &            &           &           &            &              &              &            &            &            &             &           &            &                 &             &            &       0.80 &           0.57 &         0.81 &         0.70 &       0.68 &          0.59 \\
DSG1      &               &            &           &           &            &              &              &            &            &            &             &           &            &                 &             &            &            &           0.78 &         0.96 &         1.04 &       0.97 &          0.72 \\
SERPINB5  &               &            &           &           &            &              &              &            &            &            &             &           &            &                 &             &            &            &                &         0.67 &         0.65 &       0.96 &          0.61 \\
CASP14    &               &            &           &           &            &              &              &            &            &            &             &           &            &                 &             &            &            &                &              &         1.02 &       0.95 &          0.71 \\
KRTDAP    &               &            &           &           &            &              &              &            &            &            &             &           &            &                 &             &            &            &                &              &              &       0.93 &          0.70 \\
SBSN      &               &            &           &           &            &              &              &            &            &            &             &           &            &                 &             &            &            &                &              &              &            &          0.81 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_20.pdf}
\caption{Community 20 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 21}
This community has the following genes: GRIK3, NRXN1, GFRA3, RASGEF1C, COL28A1, COBL, XKR4, SORCS1, ERBB3, PRIMA1, ZNF536, TTYH1, PLP1, L1CAM
\\
This community has no enriched pathways below adjusted p-value $< 0.05$.

\begin{longtable}{lrrrrrrrrrrrrr}
\caption{Connectivity of community 21}\\
\toprule
{} & \rot{NRXN1} & \rot{GFRA3} & \rot{RASGEF1C} & \rot{COL28A1} & \rot{COBL} & \rot{XKR4} & \rot{SORCS1} & \rot{ERBB3} & \rot{PRIMA1} & \rot{ZNF536} & \rot{TTYH1} & \rot{PLP1} & \rot{L1CAM} \\
\midrule
\endhead
\midrule
\multicolumn{14}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
GRIK3    &        0.99 &        0.80 &           0.74 &          0.66 &       0.63 &       0.81 &         0.82 &        0.96 &         0.84 &         0.72 &        0.70 &       0.76 &        0.88 \\
NRXN1    &             &        0.95 &           0.76 &          0.76 &       0.73 &       0.79 &         0.81 &        0.83 &         0.70 &         0.75 &        0.70 &       0.94 &        0.89 \\
GFRA3    &             &             &           0.78 &          0.66 &       0.62 &       0.80 &         0.62 &        0.74 &         0.63 &         0.63 &        0.71 &       0.70 &        0.76 \\
RASGEF1C &             &             &                &          0.62 &       0.55 &       0.70 &         0.60 &        0.75 &         0.63 &         0.57 &        0.68 &       0.67 &        0.83 \\
COL28A1  &             &             &                &               &       0.68 &       0.62 &         0.74 &        0.66 &         0.55 &         0.52 &        0.64 &       0.86 &        0.65 \\
COBL     &             &             &                &               &            &       0.55 &         0.66 &        0.83 &         0.58 &         0.67 &        0.62 &       0.69 &        0.71 \\
XKR4     &             &             &                &               &            &            &         0.57 &        0.73 &         0.58 &         0.59 &        0.63 &       0.57 &        0.80 \\
SORCS1   &             &             &                &               &            &            &              &        0.85 &         0.68 &         0.80 &        0.71 &       0.75 &        0.71 \\
ERBB3    &             &             &                &               &            &            &              &             &         0.72 &         0.87 &        0.79 &       0.84 &        0.97 \\
PRIMA1   &             &             &                &               &            &            &              &             &              &         0.62 &        0.59 &       0.66 &        0.80 \\
ZNF536   &             &             &                &               &            &            &              &             &              &              &        0.56 &       0.57 &        0.68 \\
TTYH1    &             &             &                &               &            &            &              &             &              &              &             &       0.83 &        0.79 \\
PLP1     &             &             &                &               &            &            &              &             &              &              &             &            &        0.74 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_21.pdf}
\caption{Community 21 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 22}
This community has the following genes: DUOX2, DUOXA2, DUOXA1, DUOX1
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 22}\\
\toprule
Adjusted \newline P-value &                                              Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
                 0.002064 &  Thyroxine biosynthesis Homo sapiens R-HSA-209968 \\
                 0.003508 &  Amine-derived hormones Homo sapiens R-HSA-209776 \\
\end{longtable}


\begin{longtable}{lrrr}
\caption{Connectivity of community 22}\\
\toprule
{} & \rot{DUOXA2} & \rot{DUOXA1} & \rot{DUOX1} \\
\midrule
\endhead
\midrule
\multicolumn{4}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
DUOX2  &         0.95 &         1.09 &        1.02 \\
DUOXA2 &              &         0.85 &        0.76 \\
DUOXA1 &              &              &        1.31 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_22.pdf}
\caption{Community 22 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 23}
This community has the following genes: HBB, HBD, HBM, HBA2, HBA1, SLC4A1, ALAS2
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 23}\\
\toprule
Adjusted \newline P-value &                                                                               Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
                 0.000002 &  Erythrocytes take up oxygen and release carbon dioxide Homo sapiens R-HSA-1247673 \\
                 0.000004 &  Erythrocytes take up carbon dioxide and release oxygen Homo sapiens R-HSA-1237044 \\
                 0.000003 &                         O2/CO2 exchange in erythrocytes Homo sapiens R-HSA-1480926 \\
                 0.041265 &                          Scavenging of heme from plasma Homo sapiens R-HSA-2168880 \\
\end{longtable}


\begin{longtable}{lrrrrrr}
\caption{Connectivity of community 23}\\
\toprule
{} & \rot{HBD} & \rot{HBM} & \rot{HBA2} & \rot{HBA1} & \rot{SLC4A1} & \rot{ALAS2} \\
\midrule
\endhead
\midrule
\multicolumn{7}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
HBB    &      0.98 &      0.81 &       1.92 &       1.69 &         0.82 &        1.20 \\
HBD    &           &      0.70 &       0.94 &       0.95 &         0.71 &        0.95 \\
HBM    &           &           &       0.77 &       0.80 &         0.64 &        0.67 \\
HBA2   &           &           &            &       1.65 &         0.75 &        1.03 \\
HBA1   &           &           &            &            &         0.79 &        1.08 \\
SLC4A1 &           &           &            &            &              &        0.84 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_23.pdf}
\caption{Community 23 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 25}
This community has the following genes: MT2A, MT1E, MT1M, MT1A, MT1X
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 25}\\
\toprule
Adjusted \newline P-value &                                                     Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
             2.650168e-14 &        Response to metal ions Homo sapiens R-HSA-5660526 \\
             1.325084e-14 &  Metallothioneins bind metals Homo sapiens R-HSA-5661231 \\
             4.010723e-03 &                    Metabolism Homo sapiens R-HSA-1430728 \\
\end{longtable}


\begin{longtable}{lrrrr}
\caption{Connectivity of community 25}\\
\toprule
{} & \rot{MT1E} & \rot{MT1M} & \rot{MT1A} & \rot{MT1X} \\
\midrule
\endhead
\midrule
\multicolumn{5}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
MT2A &        1.1 &       0.80 &       0.40 &       0.77 \\
MT1E &            &       0.83 &       0.28 &       0.73 \\
MT1M &            &            &       0.82 &       0.82 \\
MT1A &            &            &            &       0.44 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_25.pdf}
\caption{Community 25 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 26}
This community has the following genes: CDC20, IQGAP3, ASPM, CENPF, RRM2, HJURP, KIF20A, KIFC1, MELK, CDK1, CEP55, MKI67, FOXM1, TROAP, ESPL1, DLGAP5, BUB1B, CASC5, NUSAP1, AURKB, TOP2A, KIF18B, BIRC5, UBE2C
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 26}\\
\toprule
Adjusted \newline P-value &                                                                                                                                                   Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
             4.170372e-13 &                                                                                                                  Cell Cycle Homo sapiens R-HSA-1640170 \\
             6.833814e-13 &                                                                                                           Cell Cycle, Mitotic Homo sapiens R-HSA-69278 \\
             1.337888e-10 &                                                                                                                       M Phase Homo sapiens R-HSA-68886 \\
             3.922609e-09 &                                                                                             Separation of Sister Chromatids Homo sapiens R-HSA-2467813 \\
             5.326234e-09 &                                                                                                              Mitotic Anaphase Homo sapiens R-HSA-68882 \\
             4.649109e-09 &                                                                                              Mitotic Metaphase and Anaphase Homo sapiens R-HSA-2555396 \\
             4.143579e-09 &                                                                                     Resolution of Sister Chromatid Cohesion Homo sapiens R-HSA-2500257 \\
             6.312883e-09 &                                                                                                          Mitotic Prometaphase Homo sapiens R-HSA-68877 \\
             6.318739e-07 &                                                                                                RHO GTPases Activate Formins Homo sapiens R-HSA-5663220 \\
             2.219715e-06 &                                                                                                         RHO GTPase Effectors Homo sapiens R-HSA-195258 \\
             6.827580e-06 &                                                                            APC/C-mediated degradation of cell cycle proteins Homo sapiens R-HSA-174143 \\
             6.258615e-06 &                                                                                             Regulation of mitotic cell cycle Homo sapiens R-HSA-453276 \\
             2.059520e-05 &                                                                                                     Signaling by Rho GTPases Homo sapiens R-HSA-194315 \\
             1.604433e-04 &                                                                         Cdc20:Phospho-APC/C mediated degradation of Cyclin A Homo sapiens R-HSA-174184 \\
             1.584290e-04 &                      APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint Homo sapiens R-HSA-179419 \\
             1.632901e-04 &  Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components Homo sapiens R-HSA-141405 \\
             1.536848e-04 &                                                             Inactivation of APC/C via direct inhibition of the APC/C complex Homo sapiens R-HSA-141430 \\
             1.474231e-04 &                                                                         APC/C:Cdc20 mediated degradation of mitotic proteins Homo sapiens R-HSA-176409 \\
             1.474144e-04 &                                                 Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins Homo sapiens R-HSA-176814 \\
             1.522844e-04 &                                                                                                    Mitotic Spindle Checkpoint Homo sapiens R-HSA-69618 \\
             1.643470e-04 &                                                               Regulation of APC/C activators between G1/S and early anaphase Homo sapiens R-HSA-176408 \\
             1.840547e-04 &                                                                                 APC/C:Cdc20 mediated degradation of Cyclin B Homo sapiens R-HSA-174048 \\
             2.282801e-04 &                                                                                      APC-Cdc20 mediated degradation of Nek2A Homo sapiens R-HSA-179409 \\
             1.241039e-03 &                                                                                     SUMOylation of DNA replication proteins Homo sapiens R-HSA-4615885 \\
             1.191397e-03 &                                                                                                                     Kinesins Homo sapiens R-HSA-983189 \\
             1.214539e-03 &                                                                                                      Phosphorylation of Emi1 Homo sapiens R-HSA-176417 \\
             3.464495e-03 &                                                                                                        Cell Cycle Checkpoints Homo sapiens R-HSA-69620 \\
             4.494142e-03 &                     APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 Homo sapiens R-HSA-174178 \\
             8.647695e-03 &                                                                                             Polo-like kinase mediated events Homo sapiens R-HSA-156711 \\
             9.467096e-03 &                                                                                                   G1/S-Specific Transcription Homo sapiens R-HSA-69205 \\
             9.949879e-03 &                                                                                   SUMO E3 ligases SUMOylate target proteins Homo sapiens R-HSA-3108232 \\
             1.114318e-02 &                                                                                                 Phosphorylation of the APC/C Homo sapiens R-HSA-176412 \\
             1.080551e-02 &                                                                   Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase Homo sapiens R-HSA-176407 \\
             1.053965e-02 &                                                                                                                 SUMOylation Homo sapiens R-HSA-2990846 \\
             1.373261e-02 &                                                                          Cyclin A/B1 associated events during G2/M transition Homo sapiens R-HSA-69273 \\
             1.730111e-02 &                                                                                                             G0 and Early G1 Homo sapiens R-HSA-1538133 \\
             2.318296e-02 &                                                                                                       Mitotic G1-G1/S phases Homo sapiens R-HSA-453279 \\
             2.507633e-02 &                                                        Factors involved in megakaryocyte development and platelet production Homo sapiens R-HSA-983231 \\
             2.794351e-02 &                                                                                   E2F mediated regulation of DNA replication Homo sapiens R-HSA-113510 \\
             4.307954e-02 &                                                                                                               G2/M Transition Homo sapiens R-HSA-69275 \\
             4.344375e-02 &                                                                                                       Mitotic G2-G2/M phases Homo sapiens R-HSA-453274 \\
\end{longtable}


\begin{longtable}{lrrrrrrrrrrrrrrrrrrrrrrr}
\caption{Connectivity of community 26}\\
\toprule
{} & \rot{IQGAP3} & \rot{ASPM} & \rot{CENPF} & \rot{RRM2} & \rot{HJURP} & \rot{KIF20A} & \rot{KIFC1} & \rot{MELK} & \rot{CDK1} & \rot{CEP55} & \rot{MKI67} & \rot{FOXM1} & \rot{TROAP} & \rot{ESPL1} & \rot{DLGAP5} & \rot{BUB1B} & \rot{CASC5} & \rot{NUSAP1} & \rot{AURKB} & \rot{TOP2A} & \rot{KIF18B} & \rot{BIRC5} & \rot{UBE2C} \\
\midrule
\endhead
\midrule
\multicolumn{24}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
CDC20  &          0.7 &       0.71 &        0.77 &       0.49 &        0.77 &         0.75 &        0.74 &       0.62 &       0.59 &        0.66 &        0.80 &        0.67 &        0.83 &        0.63 &         0.54 &        0.76 &        0.58 &         0.76 &        0.74 &        0.81 &         0.72 &        0.87 &        0.82 \\
IQGAP3 &              &       0.71 &        0.65 &       0.68 &        0.76 &         0.69 &        0.68 &       0.62 &       0.50 &        0.69 &        0.86 &        0.65 &        0.80 &        0.66 &         0.58 &        0.73 &        0.69 &         0.75 &        0.60 &        0.77 &         0.92 &        0.80 &        0.80 \\
ASPM   &              &            &        0.74 &       0.52 &        0.64 &         0.74 &        0.54 &       0.55 &       0.57 &        0.63 &        0.81 &        0.72 &        0.73 &        0.61 &         0.52 &        0.66 &        0.62 &         0.68 &        0.53 &        0.71 &         0.70 &        0.71 &        0.78 \\
CENPF  &              &            &             &       0.54 &        0.71 &         0.69 &        0.74 &       0.59 &       0.63 &        0.64 &        0.88 &        0.71 &        0.80 &        0.64 &         0.56 &        0.76 &        0.71 &         0.87 &        0.59 &        0.96 &         0.68 &        0.76 &        0.80 \\
RRM2   &              &            &             &            &        0.68 &         0.65 &        0.71 &       0.88 &       0.62 &        0.74 &        0.89 &        0.67 &        0.57 &        0.67 &         0.64 &        0.75 &        0.73 &         0.79 &        0.61 &        0.77 &         0.86 &        0.86 &        0.81 \\
HJURP  &              &            &             &            &             &         0.72 &        0.87 &       0.72 &       0.65 &        0.79 &        1.02 &        0.65 &        0.80 &        0.73 &         0.63 &        0.81 &        0.68 &         0.76 &        0.69 &        0.86 &         0.77 &        0.87 &        0.81 \\
KIF20A &              &            &             &            &             &              &        0.67 &       0.59 &       0.60 &        0.80 &        0.95 &        0.77 &        0.79 &        0.65 &         0.72 &        0.69 &        0.57 &         0.80 &        0.63 &        0.84 &         0.89 &        0.93 &        0.87 \\
KIFC1  &              &            &             &            &             &              &             &       0.73 &       0.62 &        0.82 &        0.87 &        0.65 &        0.79 &        0.76 &         0.58 &        0.80 &        0.73 &         0.86 &        0.81 &        0.76 &         0.76 &        0.74 &        0.88 \\
MELK   &              &            &             &            &             &              &             &            &       0.57 &        0.76 &        0.82 &        0.66 &        0.57 &        0.77 &         0.55 &        0.81 &        0.67 &         0.70 &        0.60 &        0.72 &         0.74 &        0.81 &        0.80 \\
CDK1   &              &            &             &            &             &              &             &            &            &        0.63 &        0.69 &        0.84 &        0.65 &        0.73 &         0.53 &        0.77 &        0.58 &         0.76 &        0.64 &        0.69 &         0.71 &        0.68 &        0.67 \\
CEP55  &              &            &             &            &             &              &             &            &            &             &        0.94 &        0.83 &        0.78 &        0.71 &         0.58 &        0.73 &        0.65 &         0.78 &        0.67 &        0.91 &         0.88 &        0.87 &        0.92 \\
MKI67  &              &            &             &            &             &              &             &            &            &             &             &        0.84 &        0.90 &        0.89 &         0.85 &        0.96 &        0.83 &         1.00 &        0.70 &        1.03 &         1.20 &        1.13 &        1.19 \\
FOXM1  &              &            &             &            &             &              &             &            &            &             &             &             &        0.74 &        0.71 &         0.61 &        0.69 &        0.68 &         0.84 &        0.66 &        0.82 &         0.82 &        0.82 &        0.86 \\
TROAP  &              &            &             &            &             &              &             &            &            &             &             &             &             &        0.74 &         0.61 &        0.73 &        0.64 &         0.96 &        0.64 &        0.92 &         0.86 &        0.81 &        0.80 \\
ESPL1  &              &            &             &            &             &              &             &            &            &             &             &             &             &             &         0.52 &        0.87 &        0.66 &         0.76 &        0.60 &        0.64 &         0.86 &        0.78 &        0.75 \\
DLGAP5 &              &            &             &            &             &              &             &            &            &             &             &             &             &             &              &        0.66 &        0.69 &         0.81 &        0.57 &        0.78 &         0.80 &        0.71 &        0.82 \\
BUB1B  &              &            &             &            &             &              &             &            &            &             &             &             &             &             &              &             &        0.71 &         0.85 &        0.78 &        0.92 &         0.83 &        0.99 &        0.80 \\
CASC5  &              &            &             &            &             &              &             &            &            &             &             &             &             &             &              &             &             &         0.84 &        0.53 &        0.73 &         0.76 &        0.72 &        0.83 \\
NUSAP1 &              &            &             &            &             &              &             &            &            &             &             &             &             &             &              &             &             &              &        0.84 &        1.03 &         0.90 &        0.94 &        0.94 \\
AURKB  &              &            &             &            &             &              &             &            &            &             &             &             &             &             &              &             &             &              &             &        0.74 &         0.65 &        0.75 &        0.72 \\
TOP2A  &              &            &             &            &             &              &             &            &            &             &             &             &             &             &              &             &             &              &             &             &         0.92 &        1.07 &        0.94 \\
KIF18B &              &            &             &            &             &              &             &            &            &             &             &             &             &             &              &             &             &              &             &             &              &        1.03 &        0.98 \\
BIRC5  &              &            &             &            &             &              &             &            &            &             &             &             &             &             &              &             &             &              &             &             &              &             &        0.96 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_26.pdf}
\caption{Community 26 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 27}
This community has the following genes: CLCA4, GBP6, CRNN, SPRR1A, SPRR3, SPRR1B, SPRR2D, SPRR2A, S100A14, TMPRSS11B, MUC21, A2ML1, KRT6B, KRT6C, KRT6A, KRT4, KRT78, RHCG, KRT13, DSG3, CEACAM5, TGM3, SERPINB3
\\
This community has no enriched pathways below adjusted p-value $< 0.05$.

\begin{longtable}{lrrrrrrrrrrrrrrrrrrrrrr}
\caption{Connectivity of community 27}\\
\toprule
{} & \rot{GBP6} & \rot{CRNN} & \rot{SPRR1A} & \rot{SPRR3} & \rot{SPRR1B} & \rot{SPRR2D} & \rot{SPRR2A} & \rot{S100A14} & \rot{TMPRSS11B} & \rot{MUC21} & \rot{A2ML1} & \rot{KRT6B} & \rot{KRT6C} & \rot{KRT6A} & \rot{KRT4} & \rot{KRT78} & \rot{RHCG} & \rot{KRT13} & \rot{DSG3} & \rot{CEACAM5} & \rot{TGM3} & \rot{SERPINB3} \\
\midrule
\endhead
\midrule
\multicolumn{23}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
CLCA4     &       0.66 &       1.00 &         0.73 &        1.03 &         0.65 &         0.52 &         0.85 &          0.67 &            0.75 &        1.01 &        0.65 &        0.53 &        0.72 &        0.74 &       0.97 &        0.60 &       0.87 &        1.05 &       0.79 &          0.92 &       0.83 &           0.68 \\
GBP6      &            &       0.82 &         0.65 &        0.80 &         0.54 &         0.49 &         0.69 &          0.54 &            0.64 &        0.81 &        0.64 &        0.46 &        0.50 &        0.55 &       0.83 &        0.53 &       0.73 &        0.82 &       0.63 &          0.60 &       0.71 &           0.59 \\
CRNN      &            &            &         0.91 &        1.71 &         0.76 &         0.65 &         1.04 &          0.83 &            1.03 &        1.46 &        0.87 &        0.63 &        0.82 &        0.85 &       1.50 &        0.80 &       1.26 &        1.63 &       0.87 &          0.90 &       1.01 &           0.84 \\
SPRR1A    &            &            &              &        1.00 &         0.84 &         0.60 &         1.01 &          0.65 &            0.64 &        0.97 &        0.69 &        0.71 &        0.83 &        1.00 &       0.87 &        0.64 &       0.92 &        1.08 &       0.85 &          0.71 &       0.85 &           0.73 \\
SPRR3     &            &            &              &             &         0.80 &         0.71 &         1.24 &          0.74 &            1.06 &        1.54 &        0.85 &        0.67 &        0.89 &        0.97 &       1.63 &        0.81 &       1.36 &        1.96 &       0.92 &          1.01 &       1.04 &           0.90 \\
SPRR1B    &            &            &              &             &              &         0.86 &         0.94 &          0.68 &            0.61 &        0.74 &        0.72 &        0.64 &        0.68 &        0.98 &       0.67 &        0.60 &       0.66 &        0.81 &       0.75 &          0.65 &       0.76 &           0.62 \\
SPRR2D    &            &            &              &             &              &              &         0.90 &          0.59 &            0.66 &        0.67 &        0.64 &        0.52 &        0.56 &        0.80 &       0.57 &        0.56 &       0.55 &        0.68 &       0.66 &          0.52 &       0.64 &           0.53 \\
SPRR2A    &            &            &              &             &              &              &              &          0.64 &            0.84 &        1.07 &        0.74 &        0.69 &        0.90 &        1.06 &       0.98 &        0.64 &       0.92 &        1.17 &       0.81 &          0.87 &       0.84 &           0.81 \\
S100A14   &            &            &              &             &              &              &              &               &            0.61 &        0.70 &        0.76 &        0.61 &        0.56 &        0.69 &       0.74 &        0.77 &       0.69 &        0.77 &       0.80 &          0.63 &       0.78 &           0.60 \\
TMPRSS11B &            &            &              &             &              &              &              &               &                 &        1.02 &        0.68 &        0.58 &        0.57 &        0.64 &       0.95 &        0.65 &       0.82 &        0.98 &       0.76 &          0.72 &       0.77 &           0.68 \\
MUC21     &            &            &              &             &              &              &              &               &                 &             &        0.75 &        0.62 &        0.75 &        0.86 &       1.39 &        0.73 &       1.19 &        1.52 &       0.92 &          0.88 &       1.04 &           0.81 \\
A2ML1     &            &            &              &             &              &              &              &               &                 &             &             &        0.61 &        0.62 &        0.78 &       0.82 &        0.70 &       0.71 &        0.85 &       0.77 &          0.66 &       0.76 &           0.69 \\
KRT6B     &            &            &              &             &              &              &              &               &                 &             &             &             &        0.75 &        0.83 &       0.60 &        0.65 &       0.57 &        0.70 &       0.74 &          0.57 &       0.73 &           0.59 \\
KRT6C     &            &            &              &             &              &              &              &               &                 &             &             &             &             &        1.10 &       0.71 &        0.46 &       0.73 &        0.93 &       0.67 &          0.71 &       0.67 &           0.72 \\
KRT6A     &            &            &              &             &              &              &              &               &                 &             &             &             &             &             &       0.78 &        0.62 &       0.80 &        1.02 &       0.93 &          0.81 &       0.83 &           0.81 \\
KRT4      &            &            &              &             &              &              &              &               &                 &             &             &             &             &             &            &        0.74 &       1.19 &        1.71 &       0.90 &          0.87 &       1.00 &           0.86 \\
KRT78     &            &            &              &             &              &              &              &               &                 &             &             &             &             &             &            &             &       0.63 &        0.76 &       0.76 &          0.52 &       0.85 &           0.60 \\
RHCG      &            &            &              &             &              &              &              &               &                 &             &             &             &             &             &            &             &            &        1.44 &       0.82 &          0.85 &       0.86 &           0.79 \\
KRT13     &            &            &              &             &              &              &              &               &                 &             &             &             &             &             &            &             &            &             &       1.00 &          0.99 &       1.05 &           0.94 \\
DSG3      &            &            &              &             &              &              &              &               &                 &             &             &             &             &             &            &             &            &             &            &          0.77 &       0.99 &           0.80 \\
CEACAM5   &            &            &              &             &              &              &              &               &                 &             &             &             &             &             &            &             &            &             &            &               &       0.77 &           0.71 \\
TGM3      &            &            &              &             &              &              &              &               &                 &             &             &             &             &             &            &             &            &             &            &               &            &           0.76 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_27.pdf}
\caption{Community 27 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 28}
This community has the following genes: CRP, APOA2, AGXT, ALB, FGB, FGA, FGG, AMBP, ORM1, ORM2, APOC3, APOH, AHSG, GC
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 28}\\
\toprule
Adjusted \newline P-value &                                                                                          Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
             1.967666e-12 &                                              Platelet degranulation Homo sapiens R-HSA-114608 \\
             1.443760e-12 &                         Response to elevated platelet cytosolic Ca2+ Homo sapiens R-HSA-76005 \\
             8.418296e-10 &                       Platelet activation, signaling and aggregation Homo sapiens R-HSA-76002 \\
             3.177515e-07 &                                                          Hemostasis Homo sapiens R-HSA-109582 \\
             3.782313e-05 &           GRB2:SOS provides linkage to MAPK signaling for Integrins Homo sapiens R-HSA-354194 \\
             3.151927e-05 &                     p130Cas linkage to MAPK signaling for integrins Homo sapiens R-HSA-372708 \\
             9.117835e-05 &                             Common Pathway of Fibrin Clot Formation Homo sapiens R-HSA-140875 \\
             1.512211e-04 &                                   Integrin alphaIIb beta3 signaling Homo sapiens R-HSA-354192 \\
             2.742046e-04 &                                              Lipoprotein metabolism Homo sapiens R-HSA-174824 \\
             3.200444e-04 &                                Platelet Aggregation (Plug Formation) Homo sapiens R-HSA-76009 \\
             3.157579e-04 &                                          MAP2K and MAPK activation Homo sapiens R-HSA-5674135 \\
             3.134360e-04 &                         Formation of Fibrin Clot (Clotting Cascade) Homo sapiens R-HSA-140877 \\
             6.560331e-04 &                                 Metabolism of fat-soluble vitamins Homo sapiens R-HSA-6806667 \\
             1.392103e-03 &                                  Integrin cell surface interactions Homo sapiens R-HSA-216083 \\
             1.547623e-03 &                         Lipid digestion, mobilization, and transport Homo sapiens R-HSA-73923 \\
             5.881899e-03 &                                Chylomicron-mediated lipid transport Homo sapiens R-HSA-174800 \\
             6.955034e-03 &                                        HDL-mediated lipid transport Homo sapiens R-HSA-194223 \\
             1.157183e-02 &                                Metabolism of vitamins and cofactors Homo sapiens R-HSA-196854 \\
             3.104646e-02 &                                   Retinoid metabolism and transport Homo sapiens R-HSA-975634 \\
             3.539800e-02 &                                     Scavenging of heme from plasma Homo sapiens R-HSA-2168880 \\
             3.859588e-02 &                                       GRB2 events in EGFR signaling Homo sapiens R-HSA-179812 \\
             3.684153e-02 &                                       SHC1 events in EGFR signaling Homo sapiens R-HSA-180336 \\
             3.523972e-02 &                                             SOS-mediated signalling Homo sapiens R-HSA-112412 \\
             3.377140e-02 &                                     SHC1 events in ERBB4 signaling Homo sapiens R-HSA-1250347 \\
             3.242054e-02 &                                             RAF/MAP kinase cascade Homo sapiens R-HSA-5673001 \\
             3.156192e-02 &                                       FRS-mediated FGFR2 signaling Homo sapiens R-HSA-5654700 \\
             3.039296e-02 &                                       FRS-mediated FGFR4 signaling Homo sapiens R-HSA-5654712 \\
             2.930749e-02 &                                       FRS-mediated FGFR3 signaling Homo sapiens R-HSA-5654706 \\
             2.829689e-02 &                                       FRS-mediated FGFR1 signaling Homo sapiens R-HSA-5654693 \\
             2.837945e-02 &                                            ARMS-mediated activation Homo sapiens R-HSA-170984 \\
             2.746398e-02 &                                   Signalling to p38 via RIT and RIN Homo sapiens R-HSA-187706 \\
             2.693137e-02 &                                            Frs2-mediated activation Homo sapiens R-HSA-170968 \\
             2.643351e-02 &                                              MAPK1/MAPK3 signaling Homo sapiens R-HSA-5684996 \\
             2.596735e-02 &                                     Prolonged ERK activation events Homo sapiens R-HSA-169893 \\
             2.553018e-02 &                                                Signaling by Leptin Homo sapiens R-HSA-2586552 \\
             2.542047e-02 &                                  Interleukin receptor SHC signaling Homo sapiens R-HSA-912526 \\
             2.502842e-02 &                                                   Signalling to RAS Homo sapiens R-HSA-167044 \\
             2.495083e-02 &                                 VEGFR2 mediated cell proliferation Homo sapiens R-HSA-5218921 \\
             2.546922e-02 &                                             Interleukin-2 signaling Homo sapiens R-HSA-451927 \\
             2.512008e-02 &                                                  Signalling to ERKs Homo sapiens R-HSA-187687 \\
             2.682738e-02 &                               Interleukin-3, 5 and GM-CSF signaling Homo sapiens R-HSA-512988 \\
             2.767146e-02 &                               NCAM signaling for neurite out-growth Homo sapiens R-HSA-375165 \\
             3.234204e-02 &                                  Extracellular matrix organization Homo sapiens R-HSA-1474244 \\
             3.193122e-02 &                                             IRS-mediated signalling Homo sapiens R-HSA-112399 \\
             3.122163e-02 &                                     MAPK family signaling cascades Homo sapiens R-HSA-5683057 \\
             3.148545e-02 &                                  Insulin receptor signalling cascade Homo sapiens R-HSA-74751 \\
             3.112703e-02 &                                            IGF1R signaling cascade Homo sapiens R-HSA-2428924 \\
             3.047855e-02 &  Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) Homo sapiens R-HSA-2404192 \\
             2.985654e-02 &                              IRS-related events triggered by IGF1R Homo sapiens R-HSA-2428928 \\
             2.955409e-02 &                                     FCERI mediated MAPK activation Homo sapiens R-HSA-2871796 \\
             3.580716e-02 &                                        Signaling by Insulin receptor Homo sapiens R-HSA-74752 \\
             3.513422e-02 &               Binding and Uptake of Ligands by Scavenger Receptors Homo sapiens R-HSA-2173782 \\
             3.740528e-02 &                                               VEGFA-VEGFR2 Pathway Homo sapiens R-HSA-4420097 \\
             3.838653e-02 &                                               Signaling by SCF-KIT Homo sapiens R-HSA-1433557 \\
             3.869712e-02 &                                                   Signaling by VEGF Homo sapiens R-HSA-194138 \\
             3.833996e-02 &                            Downstream signaling of activated FGFR2 Homo sapiens R-HSA-5654696 \\
             3.766733e-02 &                            Downstream signaling of activated FGFR4 Homo sapiens R-HSA-5654716 \\
             3.701790e-02 &                            Downstream signaling of activated FGFR3 Homo sapiens R-HSA-5654708 \\
             3.670912e-02 &                                                 Signaling by ERBB4 Homo sapiens R-HSA-1236394 \\
             3.672919e-02 &                                                 Signaling by FGFR4 Homo sapiens R-HSA-5654743 \\
             3.612707e-02 &                            Downstream signaling of activated FGFR1 Homo sapiens R-HSA-5654687 \\
             3.585266e-02 &                                                 Signaling by FGFR3 Homo sapiens R-HSA-5654741 \\
             3.620371e-02 &                                                 Signaling by FGFR1 Homo sapiens R-HSA-5654736 \\
             3.718062e-02 &                                      Downstream signal transduction Homo sapiens R-HSA-186763 \\
             3.753957e-02 &                                                    DAP12 signaling Homo sapiens R-HSA-2424491 \\
             4.045827e-02 &                                                   Signaling by EGFR Homo sapiens R-HSA-177929 \\
             4.115249e-02 &                                                 DAP12 interactions Homo sapiens R-HSA-2172127 \\
             4.119653e-02 &                                                 Signaling by FGFR2 Homo sapiens R-HSA-5654738 \\
             4.157124e-02 &                                                   Signaling by PDGF Homo sapiens R-HSA-186797 \\
             4.162392e-02 &                                                   Signaling by FGFR Homo sapiens R-HSA-190236 \\
             4.103958e-02 &                                                Innate Immune System Homo sapiens R-HSA-168249 \\
             4.304442e-02 &                    NGF signalling via TRKA from the plasma membrane Homo sapiens R-HSA-187037 \\
             4.274725e-02 &                                           Visual phototransduction Homo sapiens R-HSA-2187338 \\
             4.788309e-02 &                                           Signaling by Interleukins Homo sapiens R-HSA-449147 \\
             4.828042e-02 &                              Fc epsilon receptor (FCERI) signaling Homo sapiens R-HSA-2454202 \\
\end{longtable}


\begin{longtable}{lrrrrrrrrrrrrr}
\caption{Connectivity of community 28}\\
\toprule
{} & \rot{APOA2} & \rot{AGXT} & \rot{ALB} & \rot{FGB} & \rot{FGA} & \rot{FGG} & \rot{AMBP} & \rot{ORM1} & \rot{ORM2} & \rot{APOC3} & \rot{APOH} & \rot{AHSG} & \rot{GC} \\
\midrule
\endhead
\midrule
\multicolumn{14}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
CRP   &        0.46 &       0.49 &      0.51 &      0.99 &      1.01 &      0.92 &       0.53 &       0.77 &       0.53 &        0.44 &       0.65 &       0.51 &     0.74 \\
APOA2 &             &       0.68 &      0.88 &      0.84 &      0.80 &      0.81 &       0.73 &       0.66 &       0.46 &        0.77 &       0.79 &       0.82 &     0.73 \\
AGXT  &             &            &      0.82 &      0.78 &      0.76 &      0.70 &       0.64 &       0.68 &       0.52 &        0.79 &       0.81 &       0.77 &     0.73 \\
ALB   &             &            &           &      0.97 &      0.98 &      0.91 &       0.83 &       0.66 &       0.43 &        1.06 &       1.15 &       0.93 &     0.97 \\
FGB   &             &            &           &           &      1.73 &      1.49 &       0.95 &       0.95 &       0.55 &        0.84 &       1.15 &       0.93 &     1.19 \\
FGA   &             &            &           &           &           &      1.48 &       0.92 &       0.96 &       0.57 &        0.80 &       1.21 &       0.85 &     1.16 \\
FGG   &             &            &           &           &           &           &       0.85 &       0.93 &       0.51 &        0.78 &       1.08 &       0.80 &     1.13 \\
AMBP  &             &            &           &           &           &           &            &       0.60 &       0.41 &        0.73 &       0.94 &       0.87 &     0.87 \\
ORM1  &             &            &           &           &           &           &            &            &       1.02 &        0.66 &       0.81 &       0.67 &     0.82 \\
ORM2  &             &            &           &           &           &           &            &            &            &        0.45 &       0.52 &       0.43 &     0.55 \\
APOC3 &             &            &           &           &           &           &            &            &            &             &       0.98 &       0.81 &     0.76 \\
APOH  &             &            &           &           &           &           &            &            &            &             &            &       0.99 &     1.13 \\
AHSG  &             &            &           &           &           &           &            &            &            &             &            &            &     0.94 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_28.pdf}
\caption{Community 28 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 30}
This community has the following genes: ACVR1C, SLC19A3, CIDEC, ADIPOQ, KLB, SLC29A4, MLXIPL, CD36, FABP4, AQP7, KCNIP2, GPAM, LGALS12, DGAT2, THRSP, GPD1, PLIN1, CALB2, CIDEA, PLIN4, PLIN5, LIPE, PCK1, PFKFB1
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 30}\\
\toprule
Adjusted \newline P-value &                                                                                          Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
                 0.000052 &       Transcriptional regulation of white adipocyte differentiation Homo sapiens R-HSA-381340 \\
                 0.000381 &                                                         Metabolism Homo sapiens R-HSA-1430728 \\
                 0.000871 &  Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis Homo sapiens R-HSA-163560 \\
                 0.003314 &                               Metabolism of lipids and lipoproteins Homo sapiens R-HSA-556833 \\
                 0.004213 &               PKA-mediated phosphorylation of key metabolic factors Homo sapiens R-HSA-163358 \\
                 0.006923 &                                              Developmental Biology Homo sapiens R-HSA-1266738 \\
                 0.006311 &            PP2A-mediated dephosphorylation of key metabolic factors Homo sapiens R-HSA-163767 \\
                 0.007357 &            AMPK inhibits chREBP transcriptional activation activity Homo sapiens R-HSA-163680 \\
                 0.011238 &                                            Triglyceride Biosynthesis Homo sapiens R-HSA-75109 \\
                 0.012584 &                         Lipid digestion, mobilization, and transport Homo sapiens R-HSA-73923 \\
                 0.016800 &             Fatty acid, triacylglycerol, and ketone body metabolism Homo sapiens R-HSA-535734 \\
                 0.030743 &                                   Glycerophospholipid biosynthesis Homo sapiens R-HSA-1483206 \\
                 0.035447 &                                    Integration of energy metabolism Homo sapiens R-HSA-163685 \\
\end{longtable}


\begin{longtable}{lrrrrrrrrrrrrrrrrrrrrrrr}
\caption{Connectivity of community 30}\\
\toprule
{} & \rot{SLC19A3} & \rot{CIDEC} & \rot{ADIPOQ} & \rot{KLB} & \rot{SLC29A4} & \rot{MLXIPL} & \rot{CD36} & \rot{FABP4} & \rot{AQP7} & \rot{KCNIP2} & \rot{GPAM} & \rot{LGALS12} & \rot{DGAT2} & \rot{THRSP} & \rot{GPD1} & \rot{PLIN1} & \rot{CALB2} & \rot{CIDEA} & \rot{PLIN4} & \rot{PLIN5} & \rot{LIPE} & \rot{PCK1} & \rot{PFKFB1} \\
\midrule
\endhead
\midrule
\multicolumn{24}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
ACVR1C  &          0.68 &        0.69 &         0.69 &      0.60 &          0.49 &         0.51 &       0.27 &        0.36 &       0.57 &         0.72 &       0.45 &          0.67 &        0.51 &        0.43 &       0.70 &        0.83 &        0.61 &        0.71 &        0.58 &        0.60 &       0.57 &       0.64 &         0.59 \\
SLC19A3 &               &        0.74 &         0.71 &      0.58 &          0.71 &         0.58 &       0.30 &        0.45 &       0.72 &         0.67 &       0.48 &          0.77 &        0.45 &        0.44 &       0.74 &        0.91 &        0.62 &        0.78 &        0.68 &        0.72 &       0.67 &       0.71 &         0.63 \\
CIDEC   &               &             &         1.27 &      0.74 &          0.74 &         0.69 &       0.30 &        0.59 &       0.82 &         0.79 &       0.66 &          0.88 &        0.80 &        0.92 &       1.41 &        1.19 &        0.83 &        0.95 &        1.03 &        0.85 &       0.96 &       1.02 &         0.81 \\
ADIPOQ  &               &             &              &      0.80 &          0.66 &         0.59 &       0.30 &        0.56 &       0.73 &         0.74 &       0.54 &          0.93 &        0.72 &        0.80 &       1.25 &        1.11 &        0.69 &        0.99 &        0.88 &        0.77 &       0.83 &       0.88 &         0.76 \\
KLB     &               &             &              &           &          0.62 &         0.56 &       0.12 &        0.32 &       0.48 &         0.58 &       0.67 &          0.69 &        0.70 &        0.59 &       0.77 &        0.70 &        0.56 &        0.57 &        0.59 &        0.55 &       0.58 &       0.61 &         0.65 \\
SLC29A4 &               &             &              &           &               &         0.66 &       0.31 &        0.46 &       0.61 &         0.68 &       0.50 &          0.84 &        0.64 &        0.71 &       0.69 &        0.67 &        0.58 &        0.63 &        0.65 &        0.60 &       0.66 &       0.67 &         0.59 \\
MLXIPL  &               &             &              &           &               &              &       0.32 &        0.52 &       0.78 &         0.65 &       0.61 &          0.77 &        0.58 &        0.67 &       0.74 &        0.79 &        0.41 &        0.76 &        0.71 &        0.80 &       0.75 &       0.67 &         0.77 \\
CD36    &               &             &              &           &               &              &            &        0.96 &       0.58 &         0.45 &       0.14 &          0.37 &        0.25 &        0.21 &       0.38 &        0.34 &        0.36 &        0.44 &        0.41 &        0.42 &       0.52 &       0.32 &         0.30 \\
FABP4   &               &             &              &           &               &              &            &             &       0.82 &         0.54 &       0.27 &          0.52 &        0.38 &        0.46 &       0.64 &        0.59 &        0.57 &        0.69 &        0.67 &        0.54 &       0.86 &       0.57 &         0.49 \\
AQP7    &               &             &              &           &               &              &            &             &            &         0.95 &       0.48 &          0.73 &        0.50 &        0.54 &       0.88 &        0.99 &        0.67 &        0.90 &        0.95 &        0.83 &       1.01 &       0.76 &         0.80 \\
KCNIP2  &               &             &              &           &               &              &            &             &            &              &       0.54 &          0.78 &        0.55 &        0.56 &       0.88 &        0.93 &        0.69 &        0.80 &        0.84 &        0.89 &       0.80 &       0.67 &         0.80 \\
GPAM    &               &             &              &           &               &              &            &             &            &              &            &          0.58 &        0.84 &        0.73 &       0.63 &        0.66 &        0.50 &        0.45 &        0.55 &        0.46 &       0.45 &       0.58 &         0.63 \\
LGALS12 &               &             &              &           &               &              &            &             &            &              &            &               &        0.78 &        0.88 &       1.04 &        0.95 &        0.66 &        0.87 &        0.77 &        0.77 &       0.73 &       0.78 &         0.71 \\
DGAT2   &               &             &              &           &               &              &            &             &            &              &            &               &             &        1.03 &       0.79 &        0.70 &        0.58 &        0.55 &        0.65 &        0.60 &       0.53 &       0.67 &         0.55 \\
THRSP   &               &             &              &           &               &              &            &             &            &              &            &               &             &             &       0.87 &        0.79 &        0.55 &        0.63 &        0.70 &        0.59 &       0.56 &       0.77 &         0.58 \\
GPD1    &               &             &              &           &               &              &            &             &            &              &            &               &             &             &            &        1.34 &        0.79 &        1.08 &        1.09 &        0.93 &       0.94 &       0.98 &         0.92 \\
PLIN1   &               &             &              &           &               &              &            &             &            &              &            &               &             &             &            &             &        0.72 &        1.10 &        0.93 &        0.89 &       0.92 &       0.95 &         0.83 \\
CALB2   &               &             &              &           &               &              &            &             &            &              &            &               &             &             &            &             &             &        0.60 &        0.72 &        0.53 &       0.77 &       0.68 &         0.48 \\
CIDEA   &               &             &              &           &               &              &            &             &            &              &            &               &             &             &            &             &             &             &        0.92 &        0.99 &       0.89 &       0.97 &         0.84 \\
PLIN4   &               &             &              &           &               &              &            &             &            &              &            &               &             &             &            &             &             &             &             &        0.77 &       1.00 &       0.77 &         0.82 \\
PLIN5   &               &             &              &           &               &              &            &             &            &              &            &               &             &             &            &             &             &             &             &             &       0.80 &       0.83 &         0.83 \\
LIPE    &               &             &              &           &               &              &            &             &            &              &            &               &             &             &            &             &             &             &             &             &            &       0.78 &         0.70 \\
PCK1    &               &             &              &           &               &              &            &             &            &              &            &               &             &             &            &             &             &             &             &             &            &            &         0.78 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkArtery_Coronary_30.pdf}
\caption{Community 30 structure. Only showing connections with correlation greater than 0.8}
\end{figure}


